Patients with psoriasis face higher risk for several different types of cancer, according to the results of an international ...

Topicals are often the first-line treatment for psoriasis, but as the condition progresses, you may need to consider systemic treatments to manage your symptoms. Here’s what to know about your options ...

Psoriasis can involve sensitive areas like the face, palms, armpits, groin, genitals, and underneath the breasts. Here’s how ...

In psoriasis, like cancers, disease control that includes the well-being of a patient is an additional useful measure of ...

Still given JNJ has most of the rights to market and sell icontrokinra, is there any pressing need to complete a full, ...

The most common causes of an itchy scalp are dandruff, lice, psoriasis, or a stress rash. Here's how to determine which may ...

Bristol Myers Squibb Co said on Tuesday its experimental plaque psoriasis oral drug proved more effective in clearing moderate to severe cases of the skin condition than placebo or Amgen Inc's Otezla ...

A recent review explored the benefits of biosimilars for patients with moderate to severe chronic plaque psoriasis.

Icotrokinra demonstrated superiority to placebo and deucravacitinib in the treatment of adults and adolescents with moderate ...

Anti-IL-17A biologics have the greatest odds of achieving and maintaining clear or almost clear skin among patients with psoriasis.

TREMFYA® is now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children six ...

There are many reasons why patients with psoriasis seek complementary and alternative medicine (CAM). These include fear of injections, concern over side effects, and even online influences. In fact, ...